Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 May;28(2):122-8.
doi: 10.1016/j.soncn.2012.03.007.

Genetic biomarkers of cancer risk

Affiliations
Review

Genetic biomarkers of cancer risk

Kathleen A Calzone. Semin Oncol Nurs. 2012 May.

Abstract

Objectives: To provide a review of genetic biomarkers of cancer risk and associated clinical implications.

Data sources: Published literature, evidence-based guidelines.

Conclusion: Identification of the genetic variation associated with cancer risk enables the health care provider to stratify an individual's risk and personalize their cancer risk management. This may lead to a decreased cancer incidence in high-risk populations, but at a minimum, will provide the opportunity for early diagnosis that may decrease cancer morbidity and mortality.

Implications for nursing practice: Nursing implications include assessment for cancer risk, initiate referrals indicated, and delivering ongoing education and support for cancer risk management plans.

PubMed Disclaimer

Figures

FIGURE 1.
FIGURE 1.
Single nucleotide polymorphisms (SNPs).
FIGURE 2.
FIGURE 2.
ACCE model (analytic validity, clinical validity, clinical utility, and ethical, legal, and social implications) for assessing genetic tests.

References

    1. Metzker ML. Sequencing technologies - the next generation. Nat Rev Genet 2010;11:31–46. - PubMed
    1. Foulkes WD. Inherited susceptibility to common cancers. N Engl J Med 2008;359:2143–2153. - PubMed
    1. Lindor NM, McMaster ML, Lindor CJ, et al. Concise handbook of familial cancer susceptibility syndromes - second edition. J Natl Cancer Inst Monog 2008;38:1–93. - PubMed
    1. Chen S, Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 2007;25:1329–1333. - PMC - PubMed
    1. Antoniou AC, Pharoah PD, Narod S, et al. Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies. J Med Genet 2005;42:602–603. - PMC - PubMed

Substances